Home › Trials › NCT06680089

CD70-targeted immunoPET Imaging of Kidney Cancer

A Study of the Clinical Application of [18F]RCCB6 PET/ CT Imaging in the Diagnosis of Kidney Cancer

Phase 2 Interventional RenJi Hospital · NCT06680089

This study is testing a new imaging technique that uses a special marker to help doctors see kidney cancer more clearly.

Quick facts

Phase	Phase 2
Study type	Interventional
Enrollment	300 (estimated)
Ages	18 Years to 80 Years
Sex	All
Sponsor	RenJi Hospital Academic / other
Drugs / interventions	immunotherapy
Locations	1 site (Shanghai, Shanghai Municipality)
Trial ID	NCT06680089 on ClinicalTrials.gov

What this trial studies

Processing failed - manual review needed

Who should consider this trial

Good fit: Unknown

Not a fit: Unknown

Why it matters

Potential benefit: Unknown

How similar studies have performed: Unknown

Eligibility criteria

Show full inclusion / exclusion criteria

Inclusion Criteria:

1. Aged 18-80 year-old and of either sex；
2. Histologically confirmed diagnosis of kidney cancer (especially clear cell renal cell carcinoma and papillary renal cell carcinoma) or suspected kidney cancer by diagnostic imaging;
3. Capable of giving signed informed consent, including compliance with the requirements and restrictions listed in the informed consent form (ICF) and this protocol.

Exclusion Criteria:

1. Pregnancy；
2. Severe hepatic and renal insufficiency;
3. History of serious surgery in the last month;
4. Allergic to antibody or single-domain antibody radiopharmaceuticals.

Where this trial is running

Shanghai, Shanghai Municipality

Renji Hospital, School of Medicine, Shanghai Jiao Tong University — Shanghai, Shanghai Municipality, China (Recruiting)

Study contacts

Principal investigator: Weijun Wei, Ph.D. & M.D. — Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University
Study coordinator: Weijun Wei, Ph.D. & M.D.
Email: wwei@shsmu.edu.cn
Phone: 15000083153

How to participate

Review the eligibility criteria above with your treating physician.
Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.

View on ClinicalTrials.gov → Find more trials like this →

Conditions Urologic Neoplasms Urogenital Neoplasms Kidney Neoplasms Neoplasms The cluster of differentiation Kidney tumor Clear cell renal cell carcinoma ImmunoPET

Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.